skip to main content
Idioma:
Refinado por: Nome da Publicação: Diabetology and Metabolic Syndrome remover assunto: Endocrinology & Metabolism remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Impact of diabetes mellitus on arterial stiffness in a representative sample of an urban Brazilian population
Impact of diabetes mellitus on arterial stiffness in a representative sample of an urban Brazilian population
Material Type:
Artigo 		Adicionar ao Meu Espaço

Impact of diabetes mellitus on arterial stiffness in a representative sample of an urban Brazilian population

de Oliveira Alvim, Rafael ; Santos, Paulo Caleb Junior Lima ; Musso, Mariane Manso ; de Sá Cunha, Roberto ; Krieger, José Eduardo ; Mill, José Geraldo ; Pereira, Alexandre Costa

Diabetology and metabolic syndrome, 2013-08, Vol.5 (1), p.45-45, Article 45 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
2
NAFLD as a continuum: from obesity to metabolic syndrome and diabetes
NAFLD as a continuum: from obesity to metabolic syndrome and diabetes
Material Type:
Artigo 		Adicionar ao Meu Espaço

NAFLD as a continuum: from obesity to metabolic syndrome and diabetes

Godoy-Matos, Amélio F ; Silva Júnior, Wellington S ; Valerio, Cynthia M

Diabetology and metabolic syndrome, 2020-07, Vol.12 (1), p.60-60, Article 60 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
3
2024 UPDATE: the Brazilian Diabetes Society position on the management of metabolic dysfunction-associated steatotic liver disease (MASLD) in people with prediabetes or type 2 diabetes
2024 UPDATE: the Brazilian Diabetes Society position on the management of metabolic dysfunction-associated steatotic liver disease (MASLD) in people with prediabetes or type 2 diabetes
Material Type:
Artigo 		Adicionar ao Meu Espaço

2024 UPDATE: the Brazilian Diabetes Society position on the management of metabolic dysfunction-associated steatotic liver disease (MASLD) in people with prediabetes or type 2 diabetes

Godoy-Matos, Amélio F ; Valério, Cynthia Melissa ; Silva Júnior, Wellington S ; de Araujo-Neto, João Marcello ; Bertoluci, Marcello Casaccia

Diabetology and metabolic syndrome, 2024-01, Vol.16 (1), p.23-23, Article 23 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
4
Analysis of factors influencing glucose tolerance in Japanese patients with non-alcoholic fatty liver disease
Analysis of factors influencing glucose tolerance in Japanese patients with non-alcoholic fatty liver disease
Material Type:
Artigo 		Adicionar ao Meu Espaço

Analysis of factors influencing glucose tolerance in Japanese patients with non-alcoholic fatty liver disease

Ohmi, Satoko ; Ono, Masafumi ; Takata, Hiroshi ; Hirano, Seiki ; Funakoshi, Shogo ; Nishi, Yuichi ; Yoshimura, Kumiko ; Amano, Eri ; Terada, Yoshio ; Saibara, Toshiji ; Fujimoto, Shimpei

Diabetology and metabolic syndrome, 2017-09, Vol.9 (1), p.65-65, Article 65 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
5
Effects of dapagliflozin in the progression of atherosclerosis in patients with type 2 diabetes: a meta-analysis of randomized controlled trials
Effects of dapagliflozin in the progression of atherosclerosis in patients with type 2 diabetes: a meta-analysis of randomized controlled trials
Material Type:
Artigo 		Adicionar ao Meu Espaço

Effects of dapagliflozin in the progression of atherosclerosis in patients with type 2 diabetes: a meta-analysis of randomized controlled trials

Wu, Qian-Long ; Zheng, Ting ; Li, Sheng-Zhen ; Chen, Jin-An ; Xie, Zi-Chun ; Lai, Jian-Mei ; Zeng, Ji-Yuan ; Lin, Jin-Ting ; Huang, Jia-Shuan ; Lin, Min-Hua

Diabetology and metabolic syndrome, 2022-03, Vol.14 (1), p.41-41, Article 41 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
6
Empagliflozin (an SGLT2 inhibitor), alone or in combination with linagliptin (a DPP-4 inhibitor), prevents steatohepatitis in a novel mouse model of non-alcoholic steatohepatitis and diabetes
Empagliflozin (an SGLT2 inhibitor), alone or in combination with linagliptin (a DPP-4 inhibitor), prevents steatohepatitis in a novel mouse model of non-alcoholic steatohepatitis and diabetes
Material Type:
Artigo 		Adicionar ao Meu Espaço

Empagliflozin (an SGLT2 inhibitor), alone or in combination with linagliptin (a DPP-4 inhibitor), prevents steatohepatitis in a novel mouse model of non-alcoholic steatohepatitis and diabetes

Jojima, Teruo ; Tomotsune, Takanori ; Iijima, Toshie ; Akimoto, Kazumi ; Suzuki, Kunihiro ; Aso, Yoshimasa

Diabetology and metabolic syndrome, 2016-07, Vol.8 (1), p.45-45, Article 45 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
7
NAFLD in normal weight individuals
NAFLD in normal weight individuals
Material Type:
Artigo 		Adicionar ao Meu Espaço

NAFLD in normal weight individuals

DiStefano, Johanna K ; Gerhard, Glenn S

Diabetology and metabolic syndrome, 2022-03, Vol.14 (1), p.45-45, Article 45 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
8
Targeting hepatic sulfane sulfur/hydrogen sulfide signaling pathway with α-lipoic acid to prevent diabetes-induced liver injury via upregulating hepatic CSE/3-MST expression
Targeting hepatic sulfane sulfur/hydrogen sulfide signaling pathway with α-lipoic acid to prevent diabetes-induced liver injury via upregulating hepatic CSE/3-MST expression
Material Type:
Artigo 		Adicionar ao Meu Espaço

Targeting hepatic sulfane sulfur/hydrogen sulfide signaling pathway with α-lipoic acid to prevent diabetes-induced liver injury via upregulating hepatic CSE/3-MST expression

Dugbartey, George J. ; Alornyo, Karl K. ; Adams, Ismaila ; Atule, Stephen ; Obeng-Kyeremeh, Richard ; Amoah, Daniel ; Adjei, Samuel

Diabetology and metabolic syndrome, 2022-10, Vol.14 (1), p.1-148, Article 148 [Periódico revisado por pares]

London: BioMed Central

Texto completo disponível

Citações Citado por
9
Long-term treatment with metformin in the prevention of fatty liver in Zucker diabetic fatty rats
Long-term treatment with metformin in the prevention of fatty liver in Zucker diabetic fatty rats
Material Type:
Artigo 		Adicionar ao Meu Espaço

Long-term treatment with metformin in the prevention of fatty liver in Zucker diabetic fatty rats

Sui, Yi ; Kong, Xianhe ; Fan, Rongrong ; Ye, Yanbin ; Mai, Haiyan ; Zhuo, Shuyu ; Lu, Wei ; Ruan, Peishan ; Fang, Shi ; Yang, Tao

Diabetology and metabolic syndrome, 2019-11, Vol.11 (1), p.94-94, Article 94 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
10
Clinical and diagnostic characteristics of non-alcoholic fatty liver disease among Egyptian children and adolescents with type1 diabetes
Clinical and diagnostic characteristics of non-alcoholic fatty liver disease among Egyptian children and adolescents with type1 diabetes
Material Type:
Artigo 		Adicionar ao Meu Espaço

Clinical and diagnostic characteristics of non-alcoholic fatty liver disease among Egyptian children and adolescents with type1 diabetes

Abdallah, Hanaa Reyad ; Youness, Eman Refaat ; Bedeir, Manar Maher ; Abouelnaga, Marwa W ; Ezzat, Wafaa M ; Elhosary, Yasser ; El-Hariri, Hazem Mohamed ; Hussein, Mona Abd Elmotaleb A ; Ahmed, Heba R ; Eladawy, Rasha

Diabetology and metabolic syndrome, 2023-03, Vol.15 (1), p.52-52, Article 52 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.